Cardiac Safety of Intranasal Chlorpheniramine: An Exposure-Based Risk Assessment.

Alas-Pineda C, Pavón-Varela DJ, Gaitán-Zambrano K, Ferrer G

Open source

DOI
10.3390/ph19050670
Published
2026 Apr 25
Container
Pharmaceuticals (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ph19050670,
  title = {Cardiac Safety of Intranasal Chlorpheniramine: An Exposure-Based Risk Assessment.},
  author = {Alas-Pineda C and Pavón-Varela DJ and Gaitán-Zambrano K and Ferrer G},
  year = {2026},
  journal = {Pharmaceuticals (Basel, Switzerland)},
  doi = {10.3390/ph19050670},
  url = {https://doi.org/10.3390/ph19050670}
}

RIS

TY  - JOUR
TI  - Cardiac Safety of Intranasal Chlorpheniramine: An Exposure-Based Risk Assessment.
AU  - Alas-Pineda C
AU  - Pavón-Varela DJ
AU  - Gaitán-Zambrano K
AU  - Ferrer G
PY  - 2026
JO  - Pharmaceuticals (Basel, Switzerland)
DO  - 10.3390/ph19050670
UR  - https://doi.org/10.3390/ph19050670
ER  - 

APA

C, A., DJ, P., K, G., & G, F. (2026). Cardiac Safety of Intranasal Chlorpheniramine: An Exposure-Based Risk Assessment.. Pharmaceuticals (Basel, Switzerland). https://doi.org/10.3390/ph19050670

Source records